Tracks
Related Products
A TISSUE SYSTEMS PATHOLOGY TEST OUTPERFORMS STANDARD CLINICOPATHOLOGIC VARIABLES IN PREDICTING PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS.
Introduction: Shifts towards high-fat, low-fiber diets, may contribute to the rising incidence of esophageal adenocarcinoma (EAC). In mice high-fat diet promotes EAC, possibly through effects on the gut microbiome and the systemic bile acid pool…
NEOPLASTIC PROGRESSION OF BARRETT'S ESOPHAGUS AMONG ORGAN TRANSPLANT RECIPIENTS: A CASE-CONTROL STUDY
Background and aims: Several small studies reported high risk of progression to high grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) in Barrett’s esophagus (BE) patients who undergo solid organ transplantation (SOT)…
THE TISSUE SYSTEMS PATHOLOGY TEST ENABLES RISK-ALIGNED MANAGEMENT FOR PATIENTS WITH BARRETT’S ESOPHAGUS
INTRODUCTION: The goal of Barrett’s esophagus (BE) surveillance is to detect dysplasia and esophageal adenocarcinoma (EAC) at early, treatable stages…
